| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $90.9M | +43.3% |
| SG&A Expense | $28.1M | +21.9% |
| Operating Income | -$119.0M | -37.6% |
| Income Tax | $0 | — |
| Net Income | -$113.8M | -32.3% |
| EPS (Basic) | -$2.61 | +0.4% |
| EPS (Diluted) | -$2.61 | +0.4% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $37.5M | -38.3% |
| Short-term Investments | $314.6M | +77.5% |
| Current Assets | $360.7M | +46.8% |
| Total Assets | $472.9M | +72.7% |
| Current Liabilities | $22.0M | +70.3% |
| Total Liabilities | $100.7M | +339.2% |
| Stockholders' Equity | $372.2M | +48.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$57.0M | +16.1% |
| Capital Expenditures | $47.1M | +837.5% |
| Investing Cash Flow | -$184.7M | -667.7% |
| Financing Cash Flow | $219.0M | — |
| Free Cash Flow | -$104.1M | -42.7% |